Literature DB >> 12226819

Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody.

W Pumeechockchai1, D Bevitt, K Agarwal, T Petropoulou, B C A Langer, B Belohradsky, M F Bassendine, G L Toms.   

Abstract

The purpose of this study was to analyse the influence of the humoral immune response on the generation and clearance of hepatitis C virus (HCV) RNA containing particles in the blood of chronically infected patients. Blood samples were fractionated by sequential flotation ultracentrifugation and HCV RNA was recovered in three fractions: low density of < 1.063 g/ml, intermediate density of 1.063-1.21 g/ml, and high density of > 1.21 g/ml. Serum low-density lipoproteins co-fractionated with the low-density particles, and high-density lipoproteins co-fractionated with the intermediate-density particles. Immunoglobulins were found exclusively in the high-density fractions. In patients with congenital immunodeficiencies, with no or low serum antibodies to the virus, mean HCV RNA titres were equal in each fraction, at approximately 10(5) IU/ml. In antibody-positive, immunocompetent patients, however, virus titres in the low-density fraction and those in the high-density fraction were reduced or absent in most patients, suggesting that virus particles in these fractions are subject to antibody-mediated clearance. Particles of intermediate density were approximately equal in titre in both patient groups, suggesting that these particles are neither generated by, nor cleared, as a result of the humoral immune response. Immunoprecipitation experiments indicated that particles of intermediate density were not complexed with either high-density lipoprotein or immunoglobulins. Elucidation of the mechanisms by which these particles are generated and maintained in the blood may provide valuable insight into the mechanism of virus persistence. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226819     DOI: 10.1002/jmv.10208

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  23 in total

1.  Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.

Authors:  Naoki Fujita; Mamoru Nakanishi; Jun Mukai; Yuuji Naito; Takafumi Ichida; Masahiko Kaito; Toshikazu Yoshikawa; Yoshiyuki Takei
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

2.  Hepatitis C virus heterogeneity: lipoprotein and immunoglobulin binding and clinical status.

Authors:  Nikki Rae Adler; Marian Biddle; Lauren Beswick; Christopher Hair; Benjamin Allen; Stephen Graves; Aminul Islam; Jonathan P Watson
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

3.  Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture.

Authors:  Pablo Gastaminza; Kelly A Dryden; Bryan Boyd; Malcolm R Wood; Mansun Law; Mark Yeager; Francis V Chisari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation.

Authors:  Pierluigi Toniutto; Carlo Fabris; Claudio Avellini; Rosalba Minisini; Davide Bitetto; Elisabetta Rossi; Carlo Smirne; Mario Pirisi
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

5.  An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.

Authors:  Birke Bartosch; Géraldine Verney; Marlène Dreux; Peggy Donot; Yoann Morice; François Penin; Jean-Michel Pawlotsky; Dimitri Lavillette; Francois-Loïc Cosset
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.

Authors:  Pablo Gastaminza; Sharookh B Kapadia; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

7.  Morphological characterization and fusion properties of triglyceride-rich lipoproteins obtained from cells transduced with hepatitis C virus glycoproteins.

Authors:  Eve-Isabelle Pécheur; Olivier Diaz; Jennifer Molle; Vinca Icard; Pierre Bonnafous; Olivier Lambert; Patrice André
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

8.  Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.

Authors:  Pablo Gastaminza; Guofeng Cheng; Stefan Wieland; Jin Zhong; Wei Liao; Francis V Chisari
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

9.  Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.

Authors:  Vinca Icard; Olivier Diaz; Caroline Scholtes; Laure Perrin-Cocon; Christophe Ramière; Ralf Bartenschlager; Francois Penin; Vincent Lotteau; Patrice André
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

Review 10.  Hepatitis C Virus entry: the early steps in the viral replication cycle.

Authors:  Ali Sabahi
Journal:  Virol J       Date:  2009-07-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.